Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Impact of previous adjuvant oxaliplatin combination therapy on survival in elderly colorectal cancer patients with recurrence.
Authors
Yusuke Nagata
Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
Yusuke Nagata , Katsushi Amano , Hayato Mikuni , Tomohiro Kano , Masashi Ishikawa , Utako Ishimoto , Takashi Nishimura , Masaaki Noguchi , Ryoichi Sawada , Tomonori Imakita , Masahisa Ohkuma , Hiroaki Aoki , Eijiro Nagasaki , Makoto Kosuge , Atsushi Hokari , Masaichi Ogawa , Ken Eto , Masayuki Saruta
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.048
Abstract #
48
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world impact on overall survival of oxaliplatin-based adjuvant chemotherapy in older patients with colorectal cancer in Mexico.
First Author: Marytere Herrera
Poster
2021 ASCO Annual Meeting
JCOG1805 (PanDRa-BD study): A randomized controlled study of adjuvant chemotherapy for stage II colorectal cancer patients at high-risk of developing recurrence according to T-stage and three selected pathological factors (Pn, DR, and BD).
First Author: Megumi Ishiguro
Poster
2021 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy (AC) choices: An analysis of elderly Australian patients with stage III colorectal cancer (CRC).
First Author: Oliver Piercey
Poster
2020 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy (AC) for stage III colorectal cancer (CRC) in the elderly: An Irish experience.
First Author: Emily Harrold